Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16401-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#16401-1-AP, RRID:AB_2186673
- Product name
- PISD antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated PISD antibody (Cat. #16401-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Screening and diagnosis of triple negative breast cancer based on rapid metabolic fingerprinting by conductive polymer spray ionization mass spectrometry and machine learning.
Metabolic changes induced by TGF-β1 via reduced expression of phosphatidylserine decarboxylase during myofibroblast transition.
LACTB suppresses melanoma progression by attenuating PP1A and YAP interaction.
The Mitochondrial Transacylase, Tafazzin, Regulates for AML Stemness by Modulating Intracellular Levels of Phospholipids.
Song Y, Zhang Y, Xie S, Song X
Frontiers in cell and developmental biology 2022;10:1075810
Frontiers in cell and developmental biology 2022;10:1075810
Metabolic changes induced by TGF-β1 via reduced expression of phosphatidylserine decarboxylase during myofibroblast transition.
Uchida N, Shimizu Y, Fujimaki M, Horibata Y, Nakamura Y, Horigane Y, Chibana K, Takemasa A, Sugimoto H, Niho S
Journal of clinical biochemistry and nutrition 2022 Mar;70(2):108-116
Journal of clinical biochemistry and nutrition 2022 Mar;70(2):108-116
LACTB suppresses melanoma progression by attenuating PP1A and YAP interaction.
Ma Y, Wang L, He F, Yang J, Ding Y, Ge S, Fan X, Zhou Y, Xu X, Jia R
Cancer letters 2021 May 28;506:67-82
Cancer letters 2021 May 28;506:67-82
The Mitochondrial Transacylase, Tafazzin, Regulates for AML Stemness by Modulating Intracellular Levels of Phospholipids.
Seneviratne AK, Xu M, Henao JJA, Fajardo VA, Hao Z, Voisin V, Xu GW, Hurren R, Kim S, MacLean N, Wang X, Gronda M, Jeyaraju D, Jitkova Y, Ketela T, Mullokandov M, Sharon D, Thomas G, Chouinard-Watkins R, Hawley JR, Schafer C, Yau HL, Khuchua Z, Aman A, Al-Awar R, Gross A, Claypool SM, Bazinet RP, Lupien M, Chan S, De Carvalho DD, Minden MD, Bader GD, Stark KD, LeBlanc P, Schimmer AD
Cell stem cell 2019 Apr 4;24(4):621-636.e16
Cell stem cell 2019 Apr 4;24(4):621-636.e16
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- K-562 cells were subjected to SDS PAGE followed by western blot with 16401-1-AP(PISD antibody) at dilution of 1:300
- Sample type
- cell line
Supportive validation
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PISD antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human PISD. This antibody recognizes human,mouse,rat antigen. The PISD antibody has been validated for the following applications: ELISA, WB, IHC analysis.
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human kidney using 16401-1-AP(PISD antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue